GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

MetLife MET · USD

Financials · Insurance · US listing · 🇺🇸 United States

S&P 500

Compare

101.67

+3.46%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

24 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 5Strong buy
  • 13Buy
  • 6Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Last close 101.67Average target 98.56

Low
90.00
Average
98.56
Median
97.00
High
105.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029
Revenue$79.39bn$83.32bn$87.14bn$92.92bn
Revenue, highest$79.96bn$84.95bn$89.54bn$95.13bn
Revenue, lowest$79.09bn$80.87bn$84.51bn$90.61bn
Earnings per share10.2411.1612.4413.60
Earnings per share, highest10.7712.0713.6814.02
Earnings per share, lowest7.417.5810.8713.16
Analysts7786

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast2.772.302.292.372.342.172.022.12
Reported2.782.432.422.582.372.021.962.08
Difference+0.4%+5.7%+5.5%+9.1%+1.2%-6.9%-2.9%-1.7%

Rating changes

Latest broker notes

  • Keefe, Bruyette & WoodsOutperform
  • JP MorganOverweight
  • BarclaysOverweight
  • TD CowenBuy
  • JP MorganOverweight
  • Keefe, Bruyette & WoodsOutperform
  • Evercore ISI GroupIn Line
  • JefferiesBuy
  • Wells FargoOverweight
  • MizuhoOutperform
  • UBSBuy
  • BarclaysOverweight

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

2 / 10

Revenue growth 2.3% a year over 10 years. Return on equity 11.9%.

Model fair value

117.67

From earnings 117.67, from revenue 83.87.

Piotroski score

4 / 9

A nine-point test of financial strength, for 31 Dec 2024.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.